📈 Markets & Finance
Live
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?
Written by Prosper Junior Bakiny for The Motley Fool -> Pfizer's financial results haven't been great, and upcoming patent cliffs could exacerbate the problem. However, the company's large pipeline
Nasdaq News — 31 July 2026
Text:
26
0
0
Pfizer's financial results haven't been great, and upcoming patent cliffs could exacerbate the problem.
However, the company's large pipeline across
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
Analysts predict Chinese stock market rebound following U.S. election results
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
📈 Markets & Finance
Investors withdraw $475 million from American Bitcoin ETFs, market confidence falters.
